an insight into time-limited therapy in cll
Published 2 years ago • 158 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
3:13
selection for time-limited & continuous therapy in cll
-
1:24
time-limited therapy in cll
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
1:34
time-limited vs continuous therapy in cll treatment
-
2:59
clinical trial updates and time-limited therapy in cll
-
2:07
moving towards time-limited treatment in frontline cll
-
7:24
what are the current cll treatment options?
-
2:57
selecting between ibrutinib, acalabrutinib and zanubrutinib in the frontline setting in cll
-
3:30
significance of watch-and-wait approach in cll
-
1:56
choosing between continuous and time-limited therapy in patients with high-risk cll
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:25
an insight into the future treatment landscape of cll
-
0:49
considering patient preference when selecting between continuous and time-limited therapy in cll
-
1:00
insights into the future of the cll treatment landscape
-
1:15
optimizing initial therapy of cll
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
0:57
unanswered questions in frontline cll treatment
-
1:29
the importance of treatment sequencing in cll
-
3:48
managing cll treatment in the future: targeted therapies and early intervention
-
1:27
what is cll treatment research focused on?
-
0:56
the current treatment landscape in cll
-
1:37
utilizing the notch1 pathway in the treatment of cll